UniQure will pursue FDA approval for Huntington gene therapy after FDA clash
The company moves forward on an FDA path for its Huntington’s gene therapy, months after a public data dispute.
By Turki Al-Mutairi·· 3 min
1 briefing · “uniqure”
The company moves forward on an FDA path for its Huntington’s gene therapy, months after a public data dispute.